Approval · Notice of Compliance 24102 · 2020
FOQUEST: Notice of Compliance 24102
Issued August 25, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24102
- Date
- August 25, 2020
- Company
- Elvium Life SciencesToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in product ownership
Products in this notice
Medicinal ingredients
- METHYLPHENIDATE HYDROCHLORIDE 25 MG per CAP
- METHYLPHENIDATE HYDROCHLORIDE 35 MG per CAP
- METHYLPHENIDATE HYDROCHLORIDE 45 MG per CAP
- METHYLPHENIDATE HYDROCHLORIDE 55 MG per CAP
- METHYLPHENIDATE HYDROCHLORIDE 70 MG per CAP
- METHYLPHENIDATE HYDROCHLORIDE 85 MG per CAP
- METHYLPHENIDATE HYDROCHLORIDE 100 MG per CAP